Current Psychiatry Reports

, Volume 12, Issue 2, pp 88–95

From TADS and SOFTADS to TORDIA and Beyond: What’s New in the Treatment of Adolescent Depression?

  • Zheya Jenny Yu
  • Christopher J. Kratochvil
  • Ronald A. Weller
  • Mira Mooreville
  • Elizabeth B. Weller

DOI: 10.1007/s11920-010-0094-x

Cite this article as:
Yu, Z.J., Kratochvil, C.J., Weller, R.A. et al. Curr Psychiatry Rep (2010) 12: 88. doi:10.1007/s11920-010-0094-x


Major depressive disorder in adolescents is associated with significant morbidity and mortality. Major advances have been made in recent years in the treatment of adolescent depression, with promising outcomes. However, limitations of currently available treatments have prompted attempts to better understand pediatric depression from a broader perspective and to develop more effective treatment strategies in the future.


AdolescentDepressionPharmacotherapyCognitive-behavioral therapy

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Zheya Jenny Yu
    • 1
  • Christopher J. Kratochvil
    • 2
  • Ronald A. Weller
    • 3
  • Mira Mooreville
    • 4
  • Elizabeth B. Weller
    • 5
  1. 1.Hall-Mercer MH/MR Center, Pennsylvania HospitalUniversity of Pennsylvania Health SystemPhiladelphiaUSA
  2. 2.University of Nebraska Medical CenterOmahaUSA
  3. 3.Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.University of MichiganAnn ArborUSA
  5. 5.The Children’s Hospital of PhiladelphiaUniversity of PennsylvaniaPhiladelphiaUSA